Moneycontrol
HomeNewsBusinessCompaniesCoronavirus impact: Wipro starts benching employees as business takes a hit
Trending Topics

Coronavirus impact: Wipro starts benching employees as business takes a hit

IT Union NITES has sent a letter to labour commissioner pointing out the impact it might have on the employees.

May 02, 2020 / 13:29 IST
Story continues below Advertisement

Wipro Ltd has started benching employees in its Pune campus at the back of COVID-19 pandemic. These employees include those working in the travel and hospitality vertical of Wipro’s BPO arm.

Following this, the Maharashtra-based IT union, National Information Technology Employees Senate (NITES) has written to the Pune labour commissioner.

Story continues below Advertisement

In the letter, NITES said, “On behalf of NITES, Maharashtra we would like to bring to your notice that we have received complaints from employees of Wipro BPO Pune Phase 2 Hinjewadi regarding putting employees on bench to maintain profitability of business under COVID-19 pandemic.”

“The company has also notified the employees on April 23, 2020 that they are on bench with immediate effect. Because of this, pay and jobs of more than 300 employees are at risk,” the letter added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show